According to research report "Asia-Pacific
Animal Health Market is expected to grow at a CAGR of 5.7%
during the forecast period to reach USD 20.25 Billion by 2021.The report
analyzes and studies the major market drivers, restraints, challenges, and
opportunities in China, Japan, India, and the Rest of Asia-Pacific
Browse 116 market data
tables and 35 figures spread through 199 pages and in-depth TOC on “Asia-Pacific Animal Health Market by Product
(Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial &
Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth
Promoter), Animal (Livestock, Companion) - Forecast to 2021"
The APAC animal health market has witnessed significant growth during the last decade and Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks. However, the shift towards vegetarian diets, rising cost of vaccine storage, and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of the APAC animal health market. Growth in companion animal ownership and rising adoption of pet health insurance in APAC offer significant growth opportunities for players operating in the APAC animal health market.
The APAC animal health market has witnessed significant growth during the last decade and Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks. However, the shift towards vegetarian diets, rising cost of vaccine storage, and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of the APAC animal health market. Growth in companion animal ownership and rising adoption of pet health insurance in APAC offer significant growth opportunities for players operating in the APAC animal health market.
Download PDF
Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485
The APAC animal health market is segmented based on
product, type of animal, and country. In 2015, the growth promoters segment
accounted for the largest share of the APAC animal health market, while the vaccines
segment is expected to witness the highest growth during the forecast period.
Growth in this segment can be attributed to the higher utilization of vaccines
as a preventive measure for various animal diseases by veterinarians, livestock
producers, and pet owners. The food-producing animals segment accounted for the
largest share of the APAC animal health market, by type of animal.
Sample of the
Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485
China is the largest regional segment for the APAC animal
health market and is expected to witness the highest growth rate during the
forecast period. The large share of this regional segment is driven by the
increasing livestock population, rising demand for animal-derived food products
in China, increasing pet ownership, and growing adoption of pet insurance. Key
players operating in this market include Zoetis, Inc. (U.S.), Sanofi (France),
Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), and Boehringer
Ingelheim GmbH (Germany).
Other players include Bayer AG (Germany), Ceva Santé
Animale (France), Virbac (France), Perrigo Company Plc. (U.S.), Vetoquinol S.A.
(France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Evonik
Industries AG (Germany).
Contact:
Mr. Shelly Singh
MarketsandMarkets™
INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com
No comments:
Post a Comment